Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Statistics

Total Valuation

FRA:C1P has a market cap or net worth of EUR 1.59 billion. The enterprise value is 1.17 billion.

Market Cap	1.59B
Enterprise Value	1.17B

Important Dates

The next estimated earnings date is Wednesday, November 19, 2025.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	Sep 4, 2025

Share Statistics

Current Share Class	847.67M
Shares Outstanding	n/a
Shares Change (YoY)	+6.04%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	463.87M

Valuation Ratios

The trailing PE ratio is 13.22 and the forward PE ratio is 11.47.

PE Ratio	13.22
Forward PE	11.47
PS Ratio	4.08
PB Ratio	2.87
P/TBV Ratio	3.27
P/FCF Ratio	11.67
P/OCF Ratio	10.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.61, with an EV/FCF ratio of 8.59.

EV / Earnings	9.73
EV / Sales	2.98
EV / EBITDA	8.61
EV / EBIT	9.07
EV / FCF	8.59

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.05.

Current Ratio	3.54
Quick Ratio	3.29
Debt / Equity	0.05
Debt / EBITDA	0.22
Debt / FCF	0.22
Interest Coverage	76.73

Financial Efficiency

Return on equity (ROE) is 23.60% and return on invested capital (ROIC) is 14.26%.

Return on Equity (ROE)	23.60%
Return on Assets (ROA)	11.58%
Return on Invested Capital (ROIC)	14.26%
Return on Capital Employed (ROCE)	22.61%
Revenue Per Employee	126,376
Profits Per Employee	39,027
Employee Count	3,164
Asset Turnover	0.56
Inventory Turnover	2.35

Taxes

In the past 12 months, FRA:C1P has paid 12.14 million in taxes.

Income Tax	12.14M
Effective Tax Rate	9.11%

Stock Price Statistics

The stock price has increased by +90.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+90.48%
50-Day Moving Average	1.45
200-Day Moving Average	1.10
Relative Strength Index (RSI)	59.65
Average Volume (20 Days)	547

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:C1P had revenue of EUR 388.35 million and earned 119.93 million in profits. Earnings per share was 0.14.

Revenue	388.35M
Gross Profit	297.54M
Operating Income	127.52M
Pretax Income	133.29M
Net Income	119.93M
EBITDA	133.57M
EBIT	127.52M
Earnings Per Share (EPS)	0.14

Balance Sheet

The company has 479.88 million in cash and 30.11 million in debt, giving a net cash position of 449.77 million.

Cash & Cash Equivalents	479.88M
Total Debt	30.11M
Net Cash	449.77M
Net Cash Per Share	n/a
Equity (Book Value)	552.29M
Book Value Per Share	0.61
Working Capital	406.30M

Cash Flow

In the last 12 months, operating cash flow was 146.12 million and capital expenditures -10.25 million, giving a free cash flow of 135.87 million.

Operating Cash Flow	146.12M
Capital Expenditures	-10.25M
Free Cash Flow	135.87M
FCF Per Share	n/a

Margins

Gross margin is 76.62%, with operating and profit margins of 32.84% and 30.88%.

Gross Margin	76.62%
Operating Margin	32.84%
Pretax Margin	34.32%
Profit Margin	30.88%
EBITDA Margin	34.39%
EBIT Margin	32.84%
FCF Margin	34.99%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 4.53%.

Dividend Per Share	0.07
Dividend Yield	4.53%
Dividend Growth (YoY)	-34.36%
Years of Dividend Growth	2
Payout Ratio	45.94%
Buyback Yield	-6.04%
Shareholder Yield	-1.52%
Earnings Yield	7.56%
FCF Yield	8.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7